Lazertinib (YH25448) is a kinase inhibitor. It affects cMET signaling, by reducing cMET receptor density, to promote ADCC.
Lazertinib (YH25448) IC50 for Cell-based and Cell-free Assays
Comprehensive IC50 Values for Lazertinib (YH25448) Across Cell-free Enzyme Inhibitory Profiles and Cell-based Functional Assays.